Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis
Clinical trial NCT02566044 · COMPLETED
Trial details
- NCT number
- NCT02566044
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-27
- Primary completion
- 2018-04-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.